Business Insider North Carolina
SEE OTHER BRANDS

Your business and economy news from North Carolina

Business Insider North Carolina: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Business Insider North Carolina.

Press releases published on June 17, 2025

Troilus Drills 78.38 g/t AuEq Over 2 m, Including 153.73 g/t AuEq Over 1 m in the Southwest Zone

Troilus Drills 78.38 g/t AuEq Over 2 m, Including 153.73 g/t AuEq Over 1 m in the Southwest Zone

MONTREAL, June 17, 2025 (GLOBE NEWSWIRE) -- Troilus Gold Corp. (“Troilus” or the “Company”, TSX: TLG; OTCQX: CHXMF; FSE: CM5R) is pleased to announce the final assay results from the Southwest Zone (“Southwest”) as part of its ongoing 2025 Exploration …

Troilus Intercepte 78,38 g/t d’équ.-Or Sur 2 m, Incluant 153,73 g/t d’équ.-Or Sur 1 m dans la Zone Southwest

Troilus Intercepte 78,38 g/t d’équ.-Or Sur 2 m, Incluant 153,73 g/t d’équ.-Or Sur 1 m dans la Zone Southwest

MONTRÉAL, 17 juin 2025 (GLOBE NEWSWIRE) -- Troilus Gold Corp. (« Troilus » ou la « Société ») (TSX: TLG; OTCQX: CHXMF; FSE: CM5R) a le plaisir d’annoncer les résultats d’analyse finaux provenant de la zone Southwest («Southwest») dans le cadre de sa …

Koryx Copper Provides Project Development Update for the Haib Copper Project, Southern Namibia

Koryx Copper Provides Project Development Update for the Haib Copper Project, Southern Namibia

Highlights Metallurgical testwork program with encouraging preliminary results including 89% average flotation recovery from 120-150µm grind size producing clean concentrate with grade of 20-25% Cu. Pre-concentration and heap leach testwork ongoing with …

Dyne Therapeutics Announces FDA Breakthrough Therapy Designation for DYNE-101 and Updated Plan for Accelerated Approval in DM1 Following Type C Meeting

Dyne Therapeutics Announces FDA Breakthrough Therapy Designation for DYNE-101 and Updated Plan for Accelerated Approval in DM1 Following Type C Meeting

- Based on Type C meeting and new data, Dyne submitted revised ACHIEVE trial protocol to FDA elevating vHOT to primary endpoint for U.S. Accelerated Approval - - New positive clinical data from Phase 1/2 ACHIEVE trial support vHOT as early indicator of …

Vireo Growth Inc. Provides Corporate Update Post Closing of All Merger Transactions

Vireo Growth Inc. Provides Corporate Update Post Closing of All Merger Transactions

MINNEAPOLIS, June 17, 2025 (GLOBE NEWSWIRE) -- Vireo Growth Inc. (“Vireo” or the “Company”) (CSE: VREO; OTCQX: VREOF), today announced a series of corporate updates following the closing of all its previously-announced definitive merger agreements, which …

Skye Bioscience to Present Expanded Preclinical CB1 Antibody Data at the American Diabetes Association’s 85th Scientific Sessions

Skye Bioscience to Present Expanded Preclinical CB1 Antibody Data at the American Diabetes Association’s 85th Scientific Sessions

SAN DIEGO, June 17, 2025 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biotechnology company focused on unlocking new therapeutic pathways for obesity and other metabolic health disorders, today announced that it was …

Inventus Reports Additional High-Grade Confirmation Drilling and Commences Bulk Sample Extraction at the Pardo Gold Project

Inventus Reports Additional High-Grade Confirmation Drilling and Commences Bulk Sample Extraction at the Pardo Gold Project

TORONTO, June 17, 2025 (GLOBE NEWSWIRE) -- Inventus Mining Corp. (TSXV: IVS) (“Inventus” or the “Company”) is pleased to announce additional high-grade assay results from grade-control drilling at Trench 1, as well as the commencement of bulk sample …

Material Update on Off-Market Takeover by Bastion Mining

Material Update on Off-Market Takeover by Bastion Mining

TORONTO, Canada, June 17, 2025 (GLOBE NEWSWIRE) -- Xanadu Mines Ltd (ASX: XAM, TSX: XAM) (Xanadu or the Company) today provides an important update in relation to the off-market takeover offer by Bastion Mining Pte. Ltd. UEN 202512367N (Bastion) to acquire …

Surge Copper Reports Excellent Metallurgical Results Supporting Pre-Feasibility Advancement at Berg Project

Surge Copper Reports Excellent Metallurgical Results Supporting Pre-Feasibility Advancement at Berg Project

Locked cycle tests exceed 90% copper and molybdenum recoveries and confirm clean final products with high separation efficiency Vancouver, British Columbia, June 17, 2025 (GLOBE NEWSWIRE) -- Surge Copper Corp. (TSXV: SURG) (OTCQB: SRGXF) (Frankfurt: G6D2) …

Oncocyte Changes Name to Insight Molecular Diagnostics Inc. (iMDx), Moves Headquarters to Nashville

Oncocyte Changes Name to Insight Molecular Diagnostics Inc. (iMDx), Moves Headquarters to Nashville

New name aligns with mission to deliver precision biomarker-based testing for both transplant and oncology care iMDx sponsoring GraftAssureIQ™ research-use-only kits at transplant labs globally Exhibiting at European Society of Organ Transplantation (ESOT) …

Fountain Asset Corp. Announces Normal Course Issuer Bid

Fountain Asset Corp. Announces Normal Course Issuer Bid

TORONTO, June 17, 2025 (GLOBE NEWSWIRE) -- Fountain Asset Corp. (TSXV: FA) (“Fountain”) announced today its intention to effect a normal course issuer bid through the facilities of the TSX Venture Exchange, subject to receipt of regulatory approval. Upon …

Mineralys Therapeutics Announces Positive Topline Results from Phase 2 Explore-CKD Trial of Lorundrostat for the Treatment of Hypertension in Subjects with CKD and Albuminuria

Mineralys Therapeutics Announces Positive Topline Results from Phase 2 Explore-CKD Trial of Lorundrostat for the Treatment of Hypertension in Subjects with CKD and Albuminuria

– Explore-CKD met its primary endpoint; lorundrostat 25 mg once daily achieved a 9.3 mmHg reduction in systolic blood pressure, and a 7.5 mmHg placebo-adjusted reduction (p=0.0024) at four weeks – – Lorundrostat showed a clinically meaningful reduction in …

Canadian Cannabis Companies Go Global Amid Rising Export Demand

Canadian Cannabis Companies Go Global Amid Rising Export Demand

Toronto, ON, June 17, 2025 (GLOBE NEWSWIRE) -- Canada is a global leader in regulated medical cannabis exports with federal legalization reinforcing its position on the international stage and giving producers a strong advantage abroad. But as global …

Beneficient Announces Court Approval of GWG Litigation Settlement

Beneficient Announces Court Approval of GWG Litigation Settlement

DALLAS, June 17, 2025 (GLOBE NEWSWIRE) -- Beneficient (NASDAQ: BENF) (“Beneficient,” “Ben” or the “Company”), a technology-enabled platform providing exit opportunities and primary capital solutions and related trust and custody services to holders of …

OROCO ANNOUNCES PRIVATE PLACEMENT

OROCO ANNOUNCES PRIVATE PLACEMENT

VANCOUVER, Canada, June 17, 2025 (GLOBE NEWSWIRE) -- Oroco Resource Corp. (TSX-V: OCO, OTC: ORRCF) (“Oroco” or the “Company”) is pleased to announce a non-brokered private placement (the “Offering”) of up to 5,000,000 units of the Company (each, a “Unit”) …

Mobilicom to Participate in the iAccess Alpha Virtual Best Ideas Summer Investment Conference 2025 on June 24–25, 2025

Mobilicom to Participate in the iAccess Alpha Virtual Best Ideas Summer Investment Conference 2025 on June 24–25, 2025

Mobilicom’s corporate presentation and investment thesis can be viewed here: LINK Palo Alto, California, June 17, 2025 (GLOBE NEWSWIRE) -- Mobilicom Limited (Nasdaq: MOB), a provider of cybersecurity and robust solutions for drones and robotics, today …

Purple Biotech Announces Initiation of Phase 2 Study of NT219 in Patients with Head and Neck Cancer

Purple Biotech Announces Initiation of Phase 2 Study of NT219 in Patients with Head and Neck Cancer

Phase 2 study, led by Dr. Antonio Jimeno at the University of Colorado Anschutz Medical Campus will evaluate NT219 in combination with either pembrolizumab or cetuximab as a strategy to overcome tumor resistance REHOVOT, Israel, June 17, 2025 (GLOBE …

ProMIS Neurosciences Presents at H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference

ProMIS Neurosciences Presents at H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference

CAMBRIDGE, Massachusetts, June 17, 2025 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (Nasdaq: PMN), a clinical-stage biotechnology company committed to the discovery and development of therapeutic antibodies selective for toxic oligomers associated with …

Antalpha Reports First Quarter 2025 Results

Antalpha Reports First Quarter 2025 Results

SINGAPORE, June 17, 2025 (GLOBE NEWSWIRE) -- - Antalpha Platform Holding Company (“Antalpha” or the “Company”) (NASDAQ: ANTA), a leading fintech platform serving the Bitcoin mining ecosystem, today announced its unaudited financial results for the first …

Die Hauptkonferenz des 17. Straits Forums wurde in Xiamen, Fujian, eröffnet

Die Hauptkonferenz des 17. Straits Forums wurde in Xiamen, Fujian, eröffnet

XIAMEN, China, June 17, 2025 (GLOBE NEWSWIRE) -- Am 15. Juni fand in Xiamen in der Provinz Fujian die Hauptkonferenz des 17. Straits Forum statt. Seit seiner Einführung im Jahr 2 009 hat das Forum mit der Mission, den Austausch zwischen den Menschen auf …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service